Skip to main content
SpringerLink
Log in

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

  • Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Introduction

Our aim was to investigate the clinical significance of premature elevated progesterone levels in women with good ovarian response treated with long gonadotropin-releasing hormone agonist (GnRH-a) cycles and IVF. Premature elevated progesterone levels refer to a rise in serum progesterone levels on the day of human chorionic gonadotrophin (hCG) administration for final oocyte maturation above a threshold level, which is usually arbitrarily defined.

Materials and methods

This is a retrospective case study, which consists of 1,045 treatment cycles in women with low P/E2 [progesterone (ng/mL) × 1,000/estradiol (pg/mL)] on the day of hCG. Elevated P levels on the day of hCG administration were defined as >1.1 ng/mL. The data of the control group (≤1.1 ng/mL, n = 900 patients) were compared with those of the high P group (>1.1 ng/mL, n = 145).

Results

Compared with the control group, those in the high progesterone group had higher levels of estradiol on the day of hCG (3,143 vs. 2,382 pg/ml) (p: 0.000) and higher numbers of MII oocytes (14.0 and 12.9) (p: 0.001). The total number of embryos and the number of good-quality embryos transferred did not differ significantly between the groups. Implantation rate (18.1 vs. 24.4%) (p: 0.008), and live birth rate (27.6 vs. 40%) (p: 0.004), were significantly lower in patients with high progesterone levels. OR and 95% CI were 0.57 (0.39–0.84) for the live birth rate.

Conclusion

In women stimulated with GnRHa and hMG/FSH for IVF, elevated serum progesterone levels on the day of hCG administration were associated with diminished implantation rates and live birth rates regardless of ovarian reserve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Younis JS, Simon A et al (1996) Endometrial preparation: lessons from oocyte donation. Fertil Steril 66(6):873–884

    CAS  PubMed  Google Scholar 

  2. Ubaldi F, Camus M et al (1996) Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 66(2):275–280

    CAS  PubMed  Google Scholar 

  3. Schoolcraft W, Sinton E et al (1991) Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 55(3):563–566

    CAS  PubMed  Google Scholar 

  4. Silverberg KM, Burns WN et al (1991) Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 73(4):797–803

    Article  CAS  PubMed  Google Scholar 

  5. Givens CR, Schriock ED et al (1994) Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 62(5):1011–1017

    CAS  PubMed  Google Scholar 

  6. Yovel I, Yaron Y et al (1995) High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril 64(1):128–131

    CAS  PubMed  Google Scholar 

  7. Randall GW, Gantt PA et al (1996) Elevated serum progesterone values at the time of ovulation induction in luteal leuprolide acetate-down-regulated GIFT cycles are associated with decreased clinical pregnancy rates. J Assist Reprod Genet 13(6):459–463

    Article  CAS  PubMed  Google Scholar 

  8. Copperman AB, Horowitz GM et al (1995) Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril 63(6):1267–1271

    CAS  PubMed  Google Scholar 

  9. Younis JS, Matilsky M et al (2001) Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril 76(2):294–299

    Article  CAS  PubMed  Google Scholar 

  10. Legro RS, Ary BA et al (1993) Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in vitro fertilization. Hum Reprod 8(9):1506–1511

    CAS  PubMed  Google Scholar 

  11. Shulman A, Ghetler Y et al (1996) The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a “long protocol” of gonadotropin-releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Genet 13(3):207–211

    Article  CAS  PubMed  Google Scholar 

  12. Fanchin R, de Ziegler D et al (1993) Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 59(5):1090–1094

    CAS  PubMed  Google Scholar 

  13. Prien SD, Canez MS et al (1994) Increases in progesterone after human chorionic gonadotropin administration may predict cycle outcome in patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 62(5):1066–1068

    CAS  PubMed  Google Scholar 

  14. Edelstein MC, Seltman HJ et al (1990) Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 54(5):853–857

    CAS  PubMed  Google Scholar 

  15. Hofmann GE, Bentzien F et al (1993) Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 60(4):675–679

    CAS  PubMed  Google Scholar 

  16. Hofmann GE, Khoury J et al (1996) Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 66(6):980–986

    CAS  PubMed  Google Scholar 

  17. Younis JS, Haddad S et al (1998) Premature luteinization: could it be an early manifestation of low ovarian reserve? Fertil Steril 69(3):461–465

    Article  CAS  PubMed  Google Scholar 

  18. Bosch E, Valencia I et al (2003) Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 80(6):1444–1449

    Article  PubMed  Google Scholar 

  19. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC (2007) Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 13(4):343–355

    Article  CAS  PubMed  Google Scholar 

  20. Ubaldi F, Albano C et al (1996) Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod 11(7):1405–1407

    CAS  PubMed  Google Scholar 

  21. Filicori M, Cognigni GE et al (2002) Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod 17(8):2009–2015

    Article  CAS  PubMed  Google Scholar 

  22. Mio Y, Sekijima A et al (1992) Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 58(1):159–166

    CAS  PubMed  Google Scholar 

  23. Lai TH, Lee FK et al (2009) An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol. Fertil Steril 92(2):508–514

    Article  CAS  PubMed  Google Scholar 

  24. Hofmann GE, Bergh PA et al (1993) Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod 8(5):695–698

    CAS  PubMed  Google Scholar 

  25. Azem F, Lessing JB et al (2008) Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? Gynecol Endocrinol 24(7):368–372

    Article  CAS  PubMed  Google Scholar 

  26. Kolibianakis E, Bourgain C et al (2002) Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 78(5):1025–1029

    Article  PubMed  Google Scholar 

  27. Papanikolaou EG, Bourgain C et al (2005) Steroid receptor expression in late follicular phase endometrium in GnRH-antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Hum Reprod 20(6):1541–1547

    Article  CAS  PubMed  Google Scholar 

  28. Barnes FL (2000) The effects of the early uterine environment on the subsequent development of embryo and fetus. Theriogenology 53(2):649–658

    Article  CAS  PubMed  Google Scholar 

  29. Papanikolaou EG, Kolibianakis EM et al (2009) Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril 91(3):949–952

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Division of Reproductive and Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Adana, Turkey

    Esra Bulgan Kiliçdag, Bulent Haydardedeoglu, Tayfun Cok, Servet Ozden Hacivelioglu & Tayfun Bagis

Authors
  1. Esra Bulgan Kiliçdag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bulent Haydardedeoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tayfun Cok
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Servet Ozden Hacivelioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tayfun Bagis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esra Bulgan Kiliçdag.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiliçdag, E.B., Haydardedeoglu, B., Cok, T. et al. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Arch Gynecol Obstet 281, 747–752 (2010). https://doi.org/10.1007/s00404-009-1248-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1248-0

Keywords

Search

Navigation